83 related articles for article (PubMed ID: 21468567)
1. (-)-Epigallocatechin gallate inhibits thyroid hormone-stimulated osteocalcin synthesis in osteoblasts.
Kato K; Otsuka T; Adachi S; Matsushima-Nishiwaki R; Natsume H; Kozawa O; Tokuda H
Mol Med Rep; 2011; 4(2):297-300. PubMed ID: 21468567
[TBL] [Abstract][Full Text] [Related]
2. (--)-epigallocatechin gallate enhances prostaglandin F2alpha-induced VEGF synthesis via upregulating SAPK/JNK activation in osteoblasts.
Tokuda H; Takai S; Matsushima-Nishiwaki R; Akamatsu S; Hanai Y; Hosoi T; Harada A; Ohta T; Kozawa O
J Cell Biochem; 2007 Apr; 100(5):1146-53. PubMed ID: 17031857
[TBL] [Abstract][Full Text] [Related]
3. Activation of p38 mitogen-activated protein kinase mediates thyroid hormone-stimulated osteocalcin synthesis in osteoblasts.
Ishisaki A; Tokuda H; Yoshida M; Hirade K; Kunieda K; Hatakeyama D; Shibata T; Kozawa O
Mol Cell Endocrinol; 2004 Feb; 214(1-2):189-95. PubMed ID: 15062557
[TBL] [Abstract][Full Text] [Related]
4. (-)-Epigallocatechin gallate amplifies interleukin-1-stimulated interleukin-6 synthesis in osteoblast-like MC3T3-E1 cells.
Kuroyanagi G; Otsuka T; Kondo A; Matsushima-Nishiwaki R; Mizutani J; Kozawa O; Tokuda H
Biochimie; 2013 Oct; 95(10):1933-8. PubMed ID: 23851196
[TBL] [Abstract][Full Text] [Related]
5. (-)-Epigallocatechin gallate reduces transforming growth factor beta-stimulated HSP27 induction through the suppression of stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts.
Hayashi K; Takai S; Matsushima-Nishiwaki R; Hanai Y; Kato K; Tokuda H; Kozawa O
Life Sci; 2008 May; 82(19-20):1012-7. PubMed ID: 18407296
[TBL] [Abstract][Full Text] [Related]
6. (-)-epigallocatechin gallate inhibits prostaglandin D2-stimulated HSP27 induction via suppression of the p44/p42 MAP kinase pathway in osteoblasts.
Yamauchi J; Takai S; Matsushima-Nishiwaki R; Hanai Y; Doi T; Kato H; Ogura S; Kato K; Tokuda H; Kozawa O
Prostaglandins Leukot Essent Fatty Acids; 2007; 77(3-4):173-9. PubMed ID: 17949962
[TBL] [Abstract][Full Text] [Related]
7. (-)-Epigallocatechin gallate suppresses endothelin-1-induced interleukin-6 synthesis in osteoblasts: inhibition of p44/p42 MAP kinase activation.
Tokuda H; Takai S; Hanai Y; Matsushima-Nishiwaki R; Hosoi T; Harada A; Ohta T; Kozawa O
FEBS Lett; 2007 Apr; 581(7):1311-6. PubMed ID: 17350626
[TBL] [Abstract][Full Text] [Related]
8. (-)-Epigallocatechin gallate reduces platelet-derived growth factor-BB-stimulated interleukin-6 synthesis in osteoblasts: suppression of SAPK/JNK.
Takai S; Matsushima-Nishiwaki R; Adachi S; Natsume H; Minamitani C; Mizutani J; Otsuka T; Tokuda H; Kozawa O
Mediators Inflamm; 2008; 2008():291808. PubMed ID: 19148296
[TBL] [Abstract][Full Text] [Related]
9. (-)-Epigallocatechin gallate inhibits basic fibroblast growth factor-stimulated interleukin-6 synthesis in osteoblasts.
Tokuda H; Takai S; Hanai Y; Matsushima-Nishiwaki R; Yamauchi J; Harada A; Hosoi T; Ohta T; Kozawa O
Horm Metab Res; 2008 Oct; 40(10):674-8. PubMed ID: 18500674
[TBL] [Abstract][Full Text] [Related]
10. (-)-Epigallocatechin gallate synergistically potentiates prostaglandin E
Kuroyanagi G; Tokuda H; Yamamoto N; Kainuma S; Fujita K; Ohguchi R; Kawabata T; Sakai G; Matsushima-Nishiwaki R; Harada A; Kozawa O; Otsuka T
Prostaglandins Other Lipid Mediat; 2017 Jan; 128-129():27-33. PubMed ID: 28163121
[TBL] [Abstract][Full Text] [Related]
11. Rho-kinase limits BMP-4-stimulated osteocalcin synthesis in osteoblasts: regulation of the p38 MAP kinase pathway.
Kondo A; Tokuda H; Matsushima-Nishiwaki R; Kuroyanagi G; Yamamoto N; Mizutani J; Kozawa O; Otsuka T
Life Sci; 2014 Feb; 96(1-2):18-25. PubMed ID: 24368139
[TBL] [Abstract][Full Text] [Related]
12. (-)-Epigallocatechin gallate attenuates the induction of HSP27 stimulated by sphingosine 1-phosphate via suppression of phosphatidylinositol 3-kinase/Akt pathway in osteoblasts.
Natsume H; Adachi S; Takai S; Tokuda H; Matsushima-Nishiwaki R; Minamitani C; Yamauchi J; Kato K; Mizutani J; Kozawa O; Otsuka T
Int J Mol Med; 2009 Aug; 24(2):197-203. PubMed ID: 19578793
[TBL] [Abstract][Full Text] [Related]
13. Divergent regulation by p44/p42 MAP kinase and p38 MAP kinase of bone morphogenetic protein-4-stimulated osteocalcin synthesis in osteoblasts.
Kozawa O; Hatakeyama D; Uematsu T
J Cell Biochem; 2002; 84(3):583-9. PubMed ID: 11813263
[TBL] [Abstract][Full Text] [Related]
14. Adenylyl cyclase-cAMP system inhibits thyroid hormone-stimulated osteocalcin synthesis in osteoblasts.
Kanno Y; Ishisaki A; Yoshida M; Nakajima K; Tokuda H; Numata O; Kozawa O
Mol Cell Endocrinol; 2005 Jan; 229(1-2):75-82. PubMed ID: 15607531
[TBL] [Abstract][Full Text] [Related]
15. Green tea polyphenol (-)-epigallocatechin gallate suppressed the differentiation of murine osteoblastic MC3T3-E1 cells.
Kamon M; Zhao R; Sakamoto K
Cell Biol Int; 2009 Dec; 34(1):109-16. PubMed ID: 19947947
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin-3-gallate, a green-tea polyphenol, suppresses Rho signaling in TWNT-4 human hepatic stellate cells.
Higashi N; Kohjima M; Fukushima M; Ohta S; Kotoh K; Enjoji M; Kobayashi N; Nakamuta M
J Lab Clin Med; 2005 Jun; 145(6):316-22. PubMed ID: 15976760
[TBL] [Abstract][Full Text] [Related]
17. Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis.
Saeki K; Kobayashi N; Inazawa Y; Zhang H; Nishitoh H; Ichijo H; Saeki K; Isemura M; Yuo A
Biochem J; 2002 Dec; 368(Pt 3):705-20. PubMed ID: 12206715
[TBL] [Abstract][Full Text] [Related]
18. Involvement of p44/p42 MAP kinase in insulin-like growth factor-I-induced alkaline phosphatase activity in osteoblast-like-MC3T3-E1 cells.
Hanai Y; Tokuda H; Ishisaki A; Matsushima-Nishiwaki R; Nakamura N; Yoshida M; Takai S; Ohta T; Kozawa O
Mol Cell Endocrinol; 2006 Jun; 251(1-2):42-8. PubMed ID: 16616413
[TBL] [Abstract][Full Text] [Related]
19. Amplification by (‑)‑epigallocatechin gallate of prostaglandin F2α‑stimulated synthesis of osteoprotegerin in osteoblasts.
Sakai G; Otsuka T; Fujita K; Kainuma S; Kuroyanagi G; Kawabata T; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
Mol Med Rep; 2017 Nov; 16(5):6376-6381. PubMed ID: 28849144
[TBL] [Abstract][Full Text] [Related]
20. Epigallocatechin-3-gallate selectively inhibits interleukin-1beta-induced activation of mitogen activated protein kinase subgroup c-Jun N-terminal kinase in human osteoarthritis chondrocytes.
Singh R; Ahmed S; Malemud CJ; Goldberg VM; Haqqi TM
J Orthop Res; 2003 Jan; 21(1):102-9. PubMed ID: 12507586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
